ContractTransition and Separation Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 JurisdictionEX-10.2 2 jazzq12018ex102.htm TRANSITION AND SEPARATION AGREEMENT Exhibit 10.2 [Jazz Pharmaceuticals Letterhead] March 24, 2018 Karen Smith Jazz Pharmaceuticals, Inc. 3170 Porter Drive Palo Alto, CA 94304 Re: Transition and Separation Agreement Dear Karen: This letter sets forth the terms of the transition and separation agreement (the “Agreement”) between you and Jazz Pharmaceuticals, Inc. (the “Company”). 1.Separation Date; Transition Employment Period; Final Base Salary and Vacation Pay-Out. If you sign, date, and return this Agreement to the Company by 5 pm on March 26, 2018, your employment with the Company will end effective as of May 31, 2018 (the “Separation Date”). During your continued employment from the date that you are provided this Agreement through the Separation Date (the “Transition Employment Period”), you will continue to report to the President and Chief Operating Officer (“COO”), and you will engage in such work activities, and operate in such capacity, as the COO
Jazz Pharmaceuticals Letterhead]Transition and Separation Agreement • May 8th, 2018 • Jazz Pharmaceuticals PLC • Pharmaceutical preparations • California
Contract Type FiledMay 8th, 2018 Company Industry JurisdictionThis letter sets forth the terms of the transition and separation agreement (the “Agreement”) between you and Jazz Pharmaceuticals, Inc. (the “Company”).